We at AOP Orphan focus on rare diseases particularly in the areas of HematoOncology, Cardiology & Pulmonology, Neurology & Metabolic Disorders. Learn more about the indications, its symptoms, diagnosis, therapies and everyday life here.

Agile, ambitious and aligned team members, mutual appreciation and commitment - this is what makes AOP Orphan a successful company and great place to work. Learn more about the company, open positions and everyday life at AOP Orphan here.

Feraccru®

Feraccru® is indicated for adults for the treatment of iron deficiency.

Drug Facts

Active Ingredient

Ferric-maltol

Availability AOP Orphan

Neurology & Metabolic Disorders

Ocaliva®

Ocaliva® is indicated for the treatment of primary biliary cholangitis (also known to as primary biliary cirrhosis) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA.

Drug Facts

Active Ingredient

Obeticholic acid

Availability AOP Orphan

Cardiology & Pulmonology

TRESUVI®

Drug Facts

Active Ingredient

Treprostinil

Availability AOP Orphan

Neurology & Metabolic Disorders

Tetmodis®

Tetmodis® is used as symptomatic therapy in the treatment of hyperkinetic motor disorders in Huntington’s disease. Tetrabenazine is also used in etiologies such as tardive dyskinesia, tics and dystonia.

Drug Facts

Active Ingredient

Tetrabenazine

Availability AOP Orphan

HematoOncology

Thromboreductin®

is used to reduce an elevated blood platelet count, thrombocyte count, in patients with essential thrombocythemia.

Drug Facts

Active Ingredient

Anagrelide

Availability AOP Orphan

Neurology & Metabolic Disorders

Wakix®

Wakix® is indicated in adults for the treatment of narcolepsy with or without cataplexy.